乌干达人类免疫缺陷病毒感染青年的亚临床血管疾病纵向变化
在乌干达开展前瞻性观察队列研究,纳入101名围产期获得人类免疫缺陷病毒(PHIV)的10-18岁青年和97名未感染对照,随访96周。PHIV组基线颈动脉内膜中层厚度略高,96周时内膜中层厚度下降而脉搏波速度升高;未感染组内膜中层厚度升高。较长抗病毒治疗时间与较低脉搏波速度相关,阿巴卡韦使用与较高内膜中层厚度相关。
要点
- PHIV青年基线颈动脉内膜中层厚度略高于未感染对照(P < .01)。
- 96周时PHIV组内膜中层厚度下降、脉搏波速度升高(P ≤ .03)。
- PHIV组较长抗病毒治疗时间与较低脉搏波速度相关。
核心结论
- 在经抗病毒治疗实现病毒抑制的健康乌干达PHIV青年中,颈动脉内膜中层厚度在2年内未进展。
- 作者认为,早期和长期抗病毒治疗可能预防亚临床血管疾病进展,而长期使用阿巴卡韦可能增加其进展。
研究设计与样本
- 前瞻性观察队列研究,2017年至2021年在乌干达联合临床研究中心开展。
- 纳入101名10-18岁PHIV青年和97名未感染人类免疫缺陷病毒(HIV-)青年。
- PHIV参与者接受抗病毒治疗且HIV-1 RNA ≤400 copies/mL,基线和96周评估颈动脉内膜中层厚度和脉搏波速度。
主要发现
- 基线198名参与者中,168名(PHIV组89名,HIV-组79名)在96周有测量数据。
- 中位年龄13(11-15)岁,52%为女性,85%病毒载量<50 copies/mL且至第96周仍检测不到。
- 基线平均颈动脉内膜中层厚度PHIV组略高于对照组(P < .01),脉搏波速度两组无差异(P = .08)。
- 第96周PHIV组内膜中层厚度下降、脉搏波速度升高(P ≤ .03);HIV-组内膜中层厚度升高(P = .03),脉搏波速度无变化(P = .92)。
- PHIV组纵向分析中,较长抗病毒治疗时间与较低脉搏波速度相关(β = .008 [95% CI, -.008 to .003]),阿巴卡韦使用与较高内膜中层厚度相关(β = .043 [.012-.074])。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prospective investigations on the risk of cardiovascular disease among youth with perinatally acquired human immunodeficiency virus (PHIV) in sub-Saharan Africa are lacking. METHODS: A prospective observational cohort study was performed in 101 youth (aged 10-18 years) with PHIV and 97 who were human immunodeficiency virus (HIV) uninfected (HIV-), from 2017 to 2021 at the Joint Clinical Research Center in Uganda. Participants with PHIV were receiving antiretroviral therapy (ART) and had HIV-1 RNA levels ≤400 copies/mL. The common carotid artery intima-media thickness (IMT) and pulse wave velocity (PWV) were evaluated at baseline and at 96 weeks. Groups were compared using unpaired t-test, and potential predictors of IMT and PWV were assessed using quantile regression. RESULTS: Of the 198 participants recruited at baseline, 168 (89 with PHIV, 79 HIV-) had measurements at 96 weeks. The median age (interquartile range) age was 13 (11-15) years; 52% were female, and 85% had viral loads <50 copies/mL that remained undetectable at week 96. The baseline mean common carotid artery IMT was slightly higher in participants with PHIV compared with controls (P < .01), and PWV did not differ between groups (P = .08). At week 96, IMT decreased and PWV increased in the PHIV group (P ≤ .03); IMT increased in the HIV- group (P = .03), with no change in PWV (P = .92). In longitudinal analyses in those with PHIV, longer ART duration was associated with lower PWV (β = .008 [95% confidence interval, -.008 to .003]), and abacavir use with greater IMT (β = .043 [.012-.074]). CONCLUSIONS: In healthy Ugandan youth with PHIV, virally suppressed by ART, the common carotid artery IMT did not progress over 2 years. Prolonged and early ART may prevent progression of subclinical vascular disease, while prolonged use of abacavir may increase it.
引用
- Dirajlal-Fargo S, Zhao C, Labbato D, et al. Longitudinal Changes in Subclinical Vascular Disease in Ugandan Youth With Human Immunodeficiency Virus. Clin Infect Dis. 2023. PMID: 36004575. doi:10.1093/cid/ciac686
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。